Heron Therapeutics, Inc. (NASDAQ:HRTX) Position Increased by JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) by 172.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 562,764 shares of the biotechnology company’s stock after purchasing an additional 356,053 shares during […]
JPMorgan Chase & Co. boosted its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) by 172.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 562,764 shares of the biotechnology company’s stock after purchasing an additional 356,053 shares during […]
